CL2007002929A1 - Procedimiento de preparacion del polimorfo b de n-{2-fluoro-5-[3-(tiofeno-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]fenil}-n-metil-acetamida que comprende reaccionar (5-amino-1h-pirazol-4-il)-tiofen-2-il-metanona con n-[5-(3-dimetilamino-acriloil)-2- - Google Patents

Procedimiento de preparacion del polimorfo b de n-{2-fluoro-5-[3-(tiofeno-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]fenil}-n-metil-acetamida que comprende reaccionar (5-amino-1h-pirazol-4-il)-tiofen-2-il-metanona con n-[5-(3-dimetilamino-acriloil)-2-

Info

Publication number: CL2007002929A1
Authority: CL; Chile
Prior art keywords: acrylile; tiofen; pirazolo; metanone; pirazol
Prior art date: 2006-10-11

Application number

CL200702929A

Other languages

English (en)

Inventor

Anglada Albert Palomer An Luis

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-11

Filing date

2007-10-11

Publication date

2008-05-16

2007-10-11 Application filed by Ferrer Int filed Critical Ferrer Int

2008-05-16 Publication of CL2007002929A1 publication Critical patent/CL2007002929A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

CL200702929A 2006-10-11 2007-10-11 Procedimiento de preparacion del polimorfo b de n-{2-fluoro-5-[3-(tiofeno-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]fenil}-n-metil-acetamida que comprende reaccionar (5-amino-1h-pirazol-4-il)-tiofen-2-il-metanona con n-[5-(3-dimetilamino-acriloil)-2- CL2007002929A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06122143A EP1956021A1 (en)	2006-10-11	2006-10-11	Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

Publications (1)

Publication Number	Publication Date
CL2007002929A1 true CL2007002929A1 (es)	2008-05-16

Family

ID=37808282

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200702929A CL2007002929A1 (es)	2006-10-11	2007-10-11	Procedimiento de preparacion del polimorfo b de n-{2-fluoro-5-[3-(tiofeno-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]fenil}-n-metil-acetamida que comprende reaccionar (5-amino-1h-pirazol-4-il)-tiofen-2-il-metanona con n-[5-(3-dimetilamino-acriloil)-2-

Country Status (23)

Country	Link
US (1)	US8008486B2 (es)
EP (2)	EP1956021A1 (es)
JP (1)	JP5270555B2 (es)
KR (1)	KR101409573B1 (es)
CN (1)	CN101573362B (es)
AR (1)	AR065831A1 (es)
AT (1)	ATE503758T1 (es)
AU (1)	AU2007306318B2 (es)
BR (1)	BRPI0717836A2 (es)
CA (1)	CA2664900C (es)
CL (1)	CL2007002929A1 (es)
DE (1)	DE602007013596D1 (es)
DK (1)	DK2081934T3 (es)
ES (1)	ES2362631T3 (es)
MX (1)	MX2009003567A (es)
NO (1)	NO342009B1 (es)
PL (1)	PL2081934T3 (es)
PT (1)	PT2081934E (es)
RU (1)	RU2404984C1 (es)
SI (1)	SI2081934T1 (es)
TW (1)	TWI425000B (es)
UY (1)	UY30619A1 (es)
WO (1)	WO2008043799A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1884516A1 (en) *	2006-08-04	2008-02-06	Ferrer Internacional, S.A.	Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6399621B1 (en) *	1999-08-10	2002-06-04	American Cyanamid Company	N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EA004706B1 (ru) *	1999-09-02	2004-06-24	Ньюрокрайн Байосайенсиз Инк.	ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ [1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ
US20020072527A1 (en) *	2000-08-03	2002-06-13	Ssci, Inc.	Polymorphs of zaleplon and methods for the preparation thereof
PT1532152E (pt) *	2002-08-26	2007-02-28	Neurocrine Biosciences Inc	Nova forma polifórmica do composto n-metil-n-(3-(3-2-tienilcarbonil[-pirazol-1,5-alfa]-pirimidin-7-il)acetamida, e composições e mátodos relacionados
ES2222813B1 (es)	2003-07-24	2005-12-16	Ferrer Internacional, S.A.	N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
US20060064488A1 (en) *	2004-09-17	2006-03-23	Ebert Robert F	Electronic software distribution method and system using a digital rights management method based on hardware identification
EP1736475A1 (en) *	2005-06-21	2006-12-27	Ferrer Internacional, S.A.	Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

2006
- 2006-10-11 EP EP06122143A patent/EP1956021A1/en not_active Withdrawn
2007
- 2007-09-28 TW TW096136170A patent/TWI425000B/zh not_active IP Right Cessation
- 2007-10-02 UY UY30619A patent/UY30619A1/es active IP Right Grant
- 2007-10-04 AR ARP070104402A patent/AR065831A1/es unknown
- 2007-10-10 RU RU2009117715/04A patent/RU2404984C1/ru not_active IP Right Cessation
- 2007-10-10 SI SI200730614T patent/SI2081934T1/sl unknown
- 2007-10-10 PL PL07821163T patent/PL2081934T3/pl unknown
- 2007-10-10 PT PT07821163T patent/PT2081934E/pt unknown
- 2007-10-10 KR KR1020097008778A patent/KR101409573B1/ko not_active Expired - Fee Related
- 2007-10-10 DE DE602007013596T patent/DE602007013596D1/de active Active
- 2007-10-10 US US12/445,221 patent/US8008486B2/en not_active Expired - Fee Related
- 2007-10-10 ES ES07821163T patent/ES2362631T3/es active Active
- 2007-10-10 WO PCT/EP2007/060796 patent/WO2008043799A1/en not_active Ceased
- 2007-10-10 CA CA2664900A patent/CA2664900C/en not_active Expired - Fee Related
- 2007-10-10 CN CN2007800378352A patent/CN101573362B/zh not_active Expired - Fee Related
- 2007-10-10 BR BRPI0717836-0A patent/BRPI0717836A2/pt not_active Application Discontinuation
- 2007-10-10 JP JP2009531842A patent/JP5270555B2/ja not_active Expired - Fee Related
- 2007-10-10 AT AT07821163T patent/ATE503758T1/de active
- 2007-10-10 EP EP07821163A patent/EP2081934B1/en not_active Not-in-force
- 2007-10-10 MX MX2009003567A patent/MX2009003567A/es active IP Right Grant
- 2007-10-10 DK DK07821163.8T patent/DK2081934T3/da active
- 2007-10-10 AU AU2007306318A patent/AU2007306318B2/en not_active Ceased
- 2007-10-11 CL CL200702929A patent/CL2007002929A1/es unknown
2009
- 2009-04-23 NO NO20091624A patent/NO342009B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP2081934B1 (en)	2011-03-30
BRPI0717836A2 (pt)	2014-05-20
ATE503758T1 (de)	2011-04-15
PL2081934T3 (pl)	2011-08-31
CA2664900A1 (en)	2008-04-17
HK1130250A1 (en)	2009-12-24
EP1956021A1 (en)	2008-08-13
DE602007013596D1 (de)	2011-05-12
RU2404984C1 (ru)	2010-11-27
DK2081934T3 (da)	2011-07-11
KR20090077806A (ko)	2009-07-15
KR101409573B1 (ko)	2014-06-19
CN101573362B (zh)	2012-06-27
SI2081934T1 (sl)	2011-07-29
MX2009003567A (es)	2009-04-14
CN101573362A (zh)	2009-11-04
US20100048896A1 (en)	2010-02-25
NO20091624L (no)	2009-05-07
TWI425000B (zh)	2014-02-01
US8008486B2 (en)	2011-08-30
AU2007306318B2 (en)	2012-07-05
CA2664900C (en)	2015-07-07
JP2010505913A (ja)	2010-02-25
PT2081934E (pt)	2011-06-29
JP5270555B2 (ja)	2013-08-21
UY30619A1 (es)	2008-03-31
ES2362631T3 (es)	2011-07-08
AR065831A1 (es)	2009-07-08
EP2081934A1 (en)	2009-07-29
NO342009B1 (no)	2018-03-12
TW200825085A (en)	2008-06-16
WO2008043799A1 (en)	2008-04-17
AU2007306318A1 (en)	2008-04-17
HK1134924A1 (en)	2010-05-20

Publication	Publication Date	Title
CY2017044I2 (el)	2018-09-05	Αντισωματα εναντι cd38 για τη θεραπεια του πολλαπλου μυελωματος
HUS1600048I1 (hu)	2017-01-30	Készítmény Fabry-kór kezelésére
IL224109A (en)	2015-06-30	Isoxazole derivatives for use as fungicides
ZA200806510B (en)	2009-11-25	Heterobicyclic sulfonamide derivatives for the treatment of diabetes
DK3309139T3 (da)	2023-12-18	Process for the preparation of 2,3,3,3-trifluoropropene
EP1992684A4 (en)	2013-04-10	INCUBATOR FOR ISOLATOR
EP2244576A4 (en)	2011-06-08	3,5-substituted-1,3-oxazolidine-2-one derivatives
FR2918570B1 (fr)	2012-10-05	DIGLYCATION DES AGEs.
BRPI0811035A2 (pt)	2014-10-21	Composições de fibrina contendo compostos de estrôncio
MY157992A (en)	2016-08-30	Catalyst for the preparation of methyl mercaptan
IL200403A0 (en)	2010-04-29	Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
EP2042164A4 (en)	2010-10-13	STABILIZED SOLID PREPARATION
BRPI0911634A2 (pt)	2016-06-14	processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas
EP2237658A4 (en)	2014-10-08	homogenizer valve
FI20065089A0 (fi)	2006-02-09	Menetelmä yhdistelmäsuolen valmistamiseksi
BRPI0820650A2 (pt)	2014-10-14	Misturas de compostos pesticidas
EE05626B1 (et)	2013-02-15	Meetod 3-(2,2,2-trimetlhdrasiinium)propionaadi dihdraadi valmistamiseks
EP1919688A4 (en)	2011-01-19	PROCESS FOR THE APPLICATION OF INGREDIENTS WITHIN A STRAW
DK2266990T3 (da)	2013-01-07	3-PHENYLPYRAZOLO(5,1-b)THIAZOLFORBINDELSE
EP2227317A4 (en)	2016-09-21	emulsifier
CL2007002929A1 (es)	2008-05-16	Procedimiento de preparacion del polimorfo b de n-{2-fluoro-5-[3-(tiofeno-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]fenil}-n-metil-acetamida que comprende reaccionar (5-amino-1h-pirazol-4-il)-tiofen-2-il-metanona con n-[5-(3-dimetilamino-acriloil)-2-
PL1896425T3 (pl)	2011-04-29	Sposób wytwarzania 5-(metylo-1H-1-ilo)-3-trifluorometylo)-benzenoaminy
IL196616A0 (en)	2009-11-18	Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide
ITMI20061848A1 (it)	2008-03-28	Procedimento per la preparazione di composti feniltetrazolici
EP1857120A4 (en)	2008-10-22	Injection for mastitis